Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2011
10/20/2011WO2011128421A1 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors
10/20/2011WO2011128265A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists
10/20/2011WO2011101304A3 Piperidine derivatives
10/20/2011WO2011092293A3 Cyclohexyl amide derivatives as crf receptor antagonists
10/20/2011WO2011082273A3 Substituted pyrrolo-aminopyrimidine compounds
10/20/2011WO2011060049A3 Spiro-oxindole mdm2 antagonists
10/20/2011US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011US20110257203 Inhibitors of bruton's tyrosine kinase
10/20/2011US20110257190 Crystalline forms
10/20/2011US20110257189 Pyrrolopyrazinone inhibitors of kinases
10/20/2011US20110257185 Reverse-turn mimetics and method relating thereto
10/20/2011US20110257173 3 (3-Pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives
10/20/2011US20110257172 3-(3-Pyrimidine-2-yl-benzyl)-[1,2,4] triazolo[4,3-b]pyrimidine derivatives
10/20/2011US20110257162 Hiv integrase inhibitors
10/20/2011US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011US20110257157 Thiolactams and uses thereof
10/20/2011US20110257154 Compounds and compositions as protein kinase inhibitors
10/20/2011US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011US20110257137 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/20/2011US20110256157 Pyrrolobenzodiazepines and conjugates thereof
10/20/2011US20110253995 Material for organic electroluminescence device and organic electroluminescence device using the same
10/20/2011US20110253944 Novel organic semiconductor compound, method for preparing same, and organic semiconductor composition, and organic semiconductor thin film and element containing the same
10/20/2011CA2796070A1 Androgen induced oxidative stress inhibitors
10/20/2011CA2794861A1 Pyrrolopyrazinone inhibitors of kinases
10/20/2011CA2793890A1 Pyrrolobenzodiazepines and conjugates thereof
10/20/2011CA2790687A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists
10/19/2011EP2376511A2 Bicyclic derivatives of morphine-6-glucuronid, process for their preparation and their application in therapy
10/19/2011EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011EP2376494A1 Dihydropyrimidopyrimidine derivatives
10/19/2011EP2376493A1 Dihydropyrimidopyrimidine derivative
10/19/2011EP2376492A1 3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
10/19/2011EP2376491A1 Pyrrolotriazines as alk and jak2 inhibitors
10/19/2011EP2376490A1 Imidazopyridine compounds
10/19/2011EP2376488A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
10/19/2011EP2376478A2 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/19/2011EP2376454A2 Inhibitors of diacylglycerol acyltransferase
10/19/2011EP2376085A1 Compounds and methods of use
10/19/2011EP1965798B1 Useful monobactam antibiotics
10/19/2011EP1891075B1 Tricyclic spiro derivatives as crth2 modulators
10/19/2011EP1613598B1 Methods of preparing aripiprazole crystalline forms
10/19/2011EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011CN202011847U Urotropine mother liquor circulating device
10/19/2011CN202010546U Urotropine defoaming reaction kettle
10/19/2011CN202010545U Urotropine reaction kettle
10/19/2011CN202010501U Urotropine tail gas ammonia recovery device with gas phase method
10/19/2011CN202010480U Device for purifying formaldehyde gas before reaction of urotropine
10/19/2011CN202010478U Urotropine mother liquid trapping device
10/19/2011CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011CN102222791A Cobalt(II) tetramethoxyphenylporphyrin (CoTMPP) ionomer stabilization to prevent electrode degradation
10/19/2011CN102219788A Method for extracting heme from blood of wild yak
10/19/2011CN102219787A Method for synthesizing 4-hydroxy pyrazolo[3,4-d]pyrimidine
10/19/2011CN101717399B Compound with pyrazine and thiazolone structure and application thereof in preparing medicament for treating diabetes mellitus
10/18/2011US8039486 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
10/18/2011US8039484 Antidiabetic bicyclic compounds
10/18/2011US8039478 Purinone derivatives as HM74A agonists
10/18/2011US8039477 Substituted pyrazolo[3,4-d]pyrimidin-4-one compounds as phosphodiesterase inhibitors
10/18/2011US8039476 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
10/18/2011US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011US8039460 CGRP receptor antagonists
10/18/2011US8039453 Vinca derivatives
10/18/2011CA2552107C Pyrrolotriazine compounds as kinase inhibitors
10/18/2011CA2517774C Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
10/18/2011CA2494049C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2011CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011WO2011127475A1 Organic photovoltaic devices comprising solution- processed substituted metal-phthalocyanines and exhibiting near-ir photo-sensitivity
10/13/2011WO2011127301A2 Covalent organic frameworks and methods of making same
10/13/2011WO2011126225A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
10/13/2011WO2011125020A1 Substituted carbazole derivatives and use thereof in organic electronics
10/13/2011WO2011124539A1 Bicyclic pyrimidinyl pyrazoles
10/13/2011WO2011124430A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
10/13/2011WO2011088160A3 Novel cyp17 inhibitors
10/13/2011WO2011049344A3 Method of preparing sitagliptin and intermediates used therein
10/13/2011US20110251215 Macrocyclic compounds and their use as kinase inhibitors
10/13/2011US20110251212 Piperazine derivatives
10/13/2011US20110251184 Substituted hydroxamic acids and uses thereof
10/13/2011US20110251183 Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
10/13/2011US20110251179 3,4-DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
10/13/2011US20110251178 Bicyclic Pyridinylpyrazoles
10/13/2011US20110251174 2,4-diamino-pyrimidines as aurora inhibitors
10/13/2011US20110251068 Parasitic plant control agent and parasitic plant control method
10/13/2011US20110250143 Process for preparing chlorins and their pharmaceutical uses
10/13/2011CA2795523A1 Bicyclic pyrimidinyl pyrazoles
10/13/2011CA2788762A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
10/12/2011EP2374807A2 An improved process for the isolation of temozolomide
10/12/2011EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011EP2373658A2 Stat3 inhibitors and therapeutic methods using the same
10/12/2011EP2373657A1 5, 7-dihydro- 6h-pyrimido ý 5, 4-d¨ý 1¨benzazepin-6-thiones as plk inhibitors
10/12/2011EP2373656A1 Cinnamido-pvrrolor[2,1-c][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof
10/12/2011EP2373655A1 Crystalline forms
10/12/2011EP2373654A1 Process for the preparation of anagrelide and analogues
10/12/2011EP2373653A1 Pyrrolopyrazinyl urea kinase inhibitors
10/12/2011EP2373318A1 Imidazopyrazine syk inhibitors
10/12/2011EP2373169A1 Imidazopyrazine syk inhibitors
10/12/2011EP2373163A1 Heterocyclic compounds and methods of use
10/12/2011EP1534285B1 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
10/12/2011CN1934101B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/12/2011CN1914177B Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
10/12/2011CN102216307A Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents
10/12/2011CN102216306A Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 573